Anti-invasive and anti-angiogenic effects of xanthohumol and its synthetic derivatives

Biomolecules and Therapeutics

Volumn 17, Issue 4, 2009, Pages 422-429

  Kim, Jung Ae ^a   Kang, Youra ^a   Thapa, Dinesh ^a   Lee, Jong Suk ^a   Park, Min A ^a   Lee, Kyung Hee ^a   Lyoo, Won Seok ^a   Lee, Yong Rok ^a  

^a Yeungnam University   (South Korea)

Author keywords

Angiogenesis; Cancer cell invasion; Matrix metalloproteinase; Xanthohumol; Xanthohumol C

Indexed keywords

4' O METHYLXANTHOHUMOL; FLAVONOID; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN; XANTHOHUMOL; XANTHOHUMOL C; XANTHOHUMOL C MOM ETHER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL INVASION; CELL LINE; CELL VIABILITY; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENZYME ACTIVITY; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SERUM;

HUMULUS LUPULUS;

EID: 73449119956     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2009.17.4.422     Document Type: Article

References (36)

1. Albini, A., Dell'Eva, R., Vené, R., Ferrari, N., Buhler, D. R., Noonan, D. M. and Fassina, G. (2006). Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J. 20, 527-529.
2. Barbara, V., Lara, D., Veerle Van, M., Herman, D., Denis De, K. and Marc, B. (2005). Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J. Cancer. 117, 889-895.
3. Bernardo, M. M. and Fridman, R. (2003). TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem. J. 374, 739-745.
4. Delmulle, L., Bellahcéne, A., Dhooge, W., Comhaire, F., Roelens, F., Huvaere, K., Heyerick, A., Castronovo, V. and De Keukeleire, D. (2006). Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13, 732-734.
5. Edwards, J. G., McLaren, J., Jones, J. L., Waller, D. A. and O'Byrne, K. J. (2003). Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Brit. J. Cancer 88, 1553-1559.
6. Galis, Z. S., Sukhova, G. K., Lark, M. W. and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503.
7. Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A., Klimo, K., Knauft, J., Neumann, I., Scherf, H. R., Frank, N., Bartsch, H. and Becker, H. (2002). Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1, 959-969.
8. Halin, C. and Detmar, M. (2008). Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol. 445, 1-25.
9. Henderson, M. C., Miranda, C. L., Stevens, J. F., Deinzer, M. L. and Buhler, D. R. (2000). In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30, 235-251.
10. Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J. and Werb, Z. (1986). Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. The Journal of Biological Chemistry. 25, 2814-2818.
11. John, A. and Tuszynski, G. (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7, 14-23.
12. Johnson, L. L., Dyer, R. and Hupe, D. J. (1998). Matrix metalloproteinases. Curr. Opin. Chem. Biol. 2, 466-471.
13. Lee, K. S., Jin, S. M., Lee, H. and Lee, Y. C. (2004). Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma. Clin. Exp. Allergy. 34, 276-284.
14. Lee, Y. R., Li, X., Lee, S. W., Yong, C. S., Hong, M. R. and Lyoo, W. S. (2008). ChemInform abstract: concise total synthesis of biologically interesting prenylated chalcone natural products: 4-O-Methylxanthohumol (VIII), xanthohumol E (XII), and sericone (XIII). Bull. Korean Chem. Soc. 29, 1205-1210.
15. Lee, Y. R. and Xia, L. (2007). ChemInform abstract: concise total synthesis of biologically interesting pyranochalcone natural products: citrunobin (Ia), boesenbergin A (Ib), boesenbergin B (IIa), xanthohumol C (IIb), and glabrachromene (IIc). Synthesis 20, 3240-3246.
16. Liabakk, N. B., Talbot, I., Smith, R. A., Wilkinson, K. and Balkwill, F. (1996). Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56, 190-196.
17. Mannello, F. and Gazzanelli, G. (2001). Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6, 479-482.
18. McCawley, L. J. and Matrisian, L. M. (2000). Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 6, 149-156.
19. Miranda, C. L., Aponso, G. L. M., Stevens, J. F., Deinzer, M. L. and Buhler, D. R. (2000a). Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1x1C7 cells. Cancer Lett. 149, 21-29.
20. Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W. and Buhler, D. R. (1999). Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 37, 271-285.
21. Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M., Frei, B., Deinzer, M. L. and Buhler, D. R. (2000b). Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 48, 3876-3884.
22. Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S., Pozzi, S., Frassoni, F., Fassina, G., Soverini, S., Albini, A. and Ferrari, N. (2008). Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol. Cancer Ther. 7, 2692-2702.
23. Mun-Bryce, S. and Rosenberg, G. A. (1998). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. J. Cerebral Blood Flow Metab. 18, 1163-1172.
24. Nikolic, D., Li, Y., Chadwick, L. R., Pauli, G. F. and van Breemen, R. B. (2005). Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 40, 289-299.
25. Pan, L., Becker, H. and Gerhäuser, C. (2005). Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol. Nutr. Food Res. 49, 837-843.
26. Park, B. C., Park, S. Y., Lee, J. S., Mousa, S. A., Kim, J. T., Kwak, M. K., Kang, K. W., Lee, E. S., Choi, H. G., Yong, C. S. and Kim, J. A. (2009). The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling. Vascul. Pharmacol. 50, 123-131.
27. Park, B. C., Thapa, D., Lee, Y. S., Kwak, M. K., Lee, E. S., Choi, H. G., Yong, C. S. and Kim, J. A. (2007). 1-Furan-2-yl-3-pyridin-2-ylpropenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. Eur. J. Pharmacol. 567, 193-197.
28. Plazar, J., Zegura, B., Lah, T. T. and Filipic, M. (2007). Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat. Res. 632, 1-8.
29. Stevens, J. F., Miranda, C. L., Frei, B. and Buhler, D. R. (2003). Inhibition of Peroxynitrite-Mediated LDL Oxidation by Prenylated Flavonoids: The α,β-Unsaturated Keto Functionality of 2'-Hydroxychalcones as a Novel Antioxidant Pharmacophore. Chem. Res. Toxicol. 16, 1277-1286.
30. Thapa, D., Lee, J. S., Park, S. Y., Bae, Y. H., Bae, S. K., Kwon, J. B., Kim, K. J., Kwak, M. K., Park, Y. J., Choi, H. G. and Kim, J. A. (2008). Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-κB- dependent manner. J. Pharmacol. Exp. Ther. 327, 353-364.
31. Vanhoecke, B., Derycke, L., Van Marck, V., Depypere, H., De Keukeleire, D. and Bracke, M. (2005). Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J. Cancer. 117, 889-895.
32. Vogel, S., Ohmayer, S., Brunner, G. and Heilmann, J. (2008). Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem. 16, 4286-4293.
33. Westermarck, J. and Kahari, V. M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
34. Wittekind, C. and Neid, M. (2005) Cancer invasion and metastasis. Oncology 69, 14-16.
35. Woessner, Jr. J. F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
36. Yang, S. F., Yang, W. E., Kuo, W. H., Chang, H. R., Chu, S. C. and Hsieh, Y. S. (2008). Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch. Oral. Biol. 53, 287-294.